FDA says Pfizer COVID vaccine looks effective for young kids
FDA scientists note that the study wasn’t large enough to detect extremely rare side effects Federal health regulators said late Friday that kid-size doses of Pfizer’s COVID-19 vaccine appear highly effective at preventing symptomatic infections in elementary school children and caused no unexpected safety issues, as the U.S. weighs beginning vaccinations in youngsters. The Food…